Thus, for all AMKL patients, AML cells were divided into CD34+/CD117+, CD34−/CD117+, CD34+/CD117− and CD34−/CD117− subsets (based on the backbone markers present in all tubes). This evidence concerns the gene CD34 and acute myeloid leukemia.